Skip to content
How It Works
Explore
Resources Ask a Question
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Ask a Question
PubMed This is a summary of 49 peer-reviewed journal articles Updated
Medical Genetics

Lysosomal Acid Lipase Deficiency (LAL-D) Patient Resource Guide

At a Glance

Lysosomal Acid Lipase Deficiency (LAL-D) is a rare genetic condition causing fat buildup in organs. It has two forms: a severe infant form (Wolman Disease) and a later-onset form (CESD). LAL-D is effectively treated with targeted enzyme replacement therapy called sebelipase alfa.

Receiving a diagnosis of Lysosomal Acid Lipase Deficiency (LAL-D) can be a shock, particularly because it is an ultra-rare condition that many doctors have never seen in their entire careers.

This guide is designed to cut through the confusion, validate your experiences, and provide you with a clear, evidence-based roadmap for understanding the disease and navigating your care. Whether you are the parent of an infant recently diagnosed with the severe form of the disease or an adult who has spent years searching for an explanation for your cholesterol and liver issues, you will find the information you need here.

Importantly, for the first time in history, there is a highly effective, targeted treatment for LAL-D. The narrative of this disease is changing from a fatal crisis to a manageable, chronic condition.

Please explore the following sections to understand every step of the LAL-D journey:

01

Understanding Your LAL-D Diagnosis

Learn what a Lysosomal Acid Lipase Deficiency (LAL-D) diagnosis means. Understand the genetics, infantile vs. later-onset forms, and Kanuma (ERT) treatment.

02

Understanding the Two Forms of LAL-D

Learn about the two forms of Lysosomal Acid Lipase Deficiency (LAL-D). Understand the differences between infantile-onset and later-onset symptoms and risks.

03

Why LAL-D is Often Misdiagnosed

Learn why Lysosomal Acid Lipase Deficiency (LAL-D) is often misdiagnosed as fatty liver, NAFLD, or high cholesterol, and how the DBS test confirms it.

04

The Science of Diagnosing LAL-D

Learn how Lysosomal Acid Lipase Deficiency (LAL-D) is diagnosed. Understand dried blood spot (DBS) testing, LIPA gene mutations, and liver biopsy results.

05

Treating and Managing LAL-D

Learn about LAL-D treatment options, including the standard of care enzyme replacement therapy (Sebelipase alfa). Understand infusions, diet, and management.

06

Long-Term Health and Living with LAL-D

Learn what to expect when living long-term with Lysosomal Acid Lipase Deficiency (LAL-D). Understand monitoring, ongoing treatments, and gene therapy research.

Common questions in this guide

What are the two forms of Lysosomal Acid Lipase Deficiency?
LAL-D presents differently depending on a person's age. In infants, it is historically known as Wolman Disease and is very severe. In older children and adults, it was known as Cholesteryl Ester Storage Disease (CESD) and often presents with more chronic symptoms.
Why is LAL-D so frequently misdiagnosed?
LAL-D is an ultra-rare condition that many doctors rarely see in practice. Because it causes lipid buildup in the body, it is frequently mistaken for much more common conditions like fatty liver disease or standard high cholesterol.
What tests are used to diagnose LAL-D?
Diagnosis is definitively confirmed using a dried blood spot (DBS) test, alongside genetic screening. A liver biopsy may also be used in some cases to help evaluate the condition and distinguish it from other liver or cholesterol disorders.
Is there a treatment available for LAL-D?
Yes, for the first time, there is a highly effective, targeted treatment for this condition. Patients can receive an enzyme replacement therapy called Sebelipase alfa (Kanuma) which helps manage the disease as a chronic condition.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Which specific subtype of LAL-D best describes my (or my child's) condition, and how does that affect our timeline for starting treatment?
  2. 2.Can you refer us to a specialized metabolic clinic or a biochemical geneticist who has direct experience managing LAL-D?
  3. 3.What is the immediate next step for coordinating with a genetic counselor to discuss testing for siblings and family planning?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

This guide is for informational purposes only and does not replace professional medical advice. Always consult a specialized metabolic clinic or biochemical geneticist for diagnosing and managing Lysosomal Acid Lipase Deficiency.

Get notified when new evidence is published on Lysosomal acid lipase deficiency.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.